Studies have shown that Exos encapsulating oxaliplatin and PGM5 antisense RNA (PGM5-AS1) (oxaliplatin/PGM5-AS1-Exos) can reverse cancer cell resistance, increasing the effectiveness of oxaliplatin and effectively inhibiting cancer cell metastasis (Hui et al., 2021). This evidence concerns the gene PGM5 and cancer.